Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2019 / Cilt: 25 - Sayı: 3

Level of Certain Oxidants and Antioxidants in Patients with Uterine Fibroids

Pages
158–162
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Decrease in these antioxidant parameters showed that the hypoxia and the balance of oxidant and antioxidant substances changes may probably have associated with the pathophysiology of uterine fibroids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: The mechanism of the leiomyoma formation process is still unknown.
📊
Key Findings & Data:A total of 64 subjects, 32 in both groups were included.
💡
Conclusion & Impact:CONCLUSION: Decrease in these antioxidant parameters showed that the hypoxia and the balance of oxidant and antioxidant substances changes may probably have associated with the pathophysiology of uterine fibroids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: The mechanism of the leiomyoma formation process is still unknown. However, the menstrual cycle is associated with hypoxia, and ongoing hypoxia is associated with cellular events leading to the conversion of myometrial cells into uterine fibroids. After the hypoxic environment, the balance of cellular cytokines and growth factors changes. It was planned to evaluate the balance of oxidative agents and the role of oxidative stress in the formation of uterine fibroids. STUDY DESIGN: The study was conducted in patients of gynecology outpatient clinic of Ankara Oncology Training and Research Hospital. Those volunteers with fibroids formed the study group, and the healthy ones were identified as the control group. A total of 64 subjects, 32 in both groups were included. The levels of catalase, ceruloplasmin, myeloperoxidase, native thiol, disulfide, and total thiol levels were investigated in groups. RESULTS: Antioxidant parameters such as native thiol, disulfide, and total thiol levels were significantly decreased in the uterine fibroid group. Catalase, ceruloplasmin, and myeloperoxidase levels were not statistically different between groups. CONCLUSION: Decrease in these antioxidant parameters showed that the hypoxia and the balance of oxidant and antioxidant substances changes may probably have associated with the pathophysiology of uterine fibroids.

🔖

Cite This Article

ÇETİNKAYA, K., AYRAL, P. A., ÇETİNKAYA, S., YAZIHAN, N., FADILOĞLU, Ş., ATASEVER, M., EREL, Ö. (2019). Level of Certain Oxidants and Antioxidants in Patients with Uterine Fibroids. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 25 - Sayı: 3, 158–162. https://ajindex.com/articles/160453

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Okolo S. Incidence, etiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22 (4):571-88
  2. Marsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 2006;33(1):59-67
  3. Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril. 1998;70 (4):687-91
  4. Tal R, Segars JH. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum Reprod Update. 2014;20(2):194-216
  5. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47 (18):326-32
  6. Borahay MA, Al-Hendy A, Kilic GS, Boehning D. Signaling pathways in leiomyoma: understanding pathobiology and implications for therapy. Mol Med. 2015; 21:242-56
  7. Eren Y, Dirik E, Neşelioğlu S, Erel Ö. Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg. 2015;115(4):643-9
  8. Başkol M, Dolbun Seçkin K, Başkol G. Advanced oxidation protein products, total thiol levels and total oxidant/antioxidant status in patients with nash. Turk J Gastroenterol. 2014;25 Suppl 1:32-7
  9. Karadag-Oncel E, Erel O, Ozsurekci Y, Caglayik DY, Kaya A, Gozel MG, et al. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever. Jpn J Infect Dis. 2014;67(1):22-6
  10. Torres-de la Roche LA, Becker S, Cezar C, Hermann A, Larbig A, Leicher L, et al. Pathobiology of myomatosis uteri: the underlying knowledge to support our clinical practice. Arch Gynecol Obstet. 2017;296(4):701-7
  11. Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol. 1998;92(4 Pt 1): 624-7
  12. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol. 2001;153(1):11-9
  13. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90(17):7915-22
  14. Cornelli U, Belcaro G, Cesarone MR, Finco A. Analysis of oxidative stress during the menstrual cycle. Reprod Biol Endocrinol. 2013;11:74
  15. Karowicz-Bilinska A, Plodzidym M, Krol J, Lewinska A, Bartosz G. Changes of markers of oxidative stress during menstrual cycle. Redox Rep. 2008;13(5):237-40
  16. Cakar